Robert A Hazlitt

发表

CDK2 inhibitors as candidate therapeutics for cisplatin- and noise-induced hearing loss

Michael R. Taylor, Asli N. Goktug, Cheng Cheng, 2018, The Journal of experimental medicine.

Progress in the Development of Preventative Drugs for Cisplatin-Induced Hearing Loss

Jaeki Min, J. Zuo, Robert A Hazlitt, 2018, Journal of medicinal chemistry.

Conversion of Methyl Ketones and Methyl Sulfones into α-Deutero-α,α-Difluoromethyl Ketones and α-Deutero-α,α-Difluoromethyl Sulfones in Three Synthetic Steps.

Changho Han, David A. Colby, Robert A Hazlitt, 2017, Tetrahedron letters.

Optimized Synthesis of a Pentafluoro-gem-diol and Conversion to a CF2Br-Glucopyranose through Trifluoroacetate-Release and Halogenation.

David A. Colby, Robert A Hazlitt, J. P. John, 2016, Tetrahedron letters.

Application of the Pentafluorosulfanyl Group as a Bioisosteric Replacement

David A. Colby, Robert A Hazlitt, Munia F Sowaileh, 2017, ChemMedChem.

Development of Second-Generation CDK2 Inhibitors for the Prevention of Cisplatin-Induced Hearing Loss.

Asli N. Goktug, Taosheng Chen, Luigi I. Iconaru, 2018, Journal of medicinal chemistry.

Generation of Magnesium Pentafluoropropen-2-olate from Hexafluoroisopropanol and Synthesis of 2,2,4,4,4-Pentafluoro-3,3-dihydroxyketones.

David A. Colby, Robert A Hazlitt, Munia F Sowaileh, 2017, The Journal of organic chemistry.

AZD5438-PROTAC: A selective CDK2 degrader that protects against cisplatin- and noise-induced hearing loss.

S. Lovas, Jaeki Min, Sarath Vijayakumar, 2021, European journal of medicinal chemistry.

Effect of Substituents and Stability of Transient Aluminum–Aminals in the Presence of Nucleophiles

David A. Colby, Robert A Hazlitt, Francis J. Barrios, 2014, Synthesis.